Award recordCONTRACT

LEADIANT BIOSCIENCES, INC.

PIID 36C26018N0488· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $3,314 net obligations· UEI XEEKF6DJLC34· MD

Description

MATULANE

First action · last action
2018-02-06 · 2019-08-08
Transactions
2
First transaction's obligation
$9,941
Base + all options value (sum of deltas)
$3,314
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40224
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$9,941$0Base award · 2018-02-06 · this action $9,941 · running total $9,941Modification P00001 · 2019-08-08 · this action -$6,628 · running total $3,314
  • Base2018-02-06+$9,941= $9,941
  • Mod P000012019-08-08-$6,628= $3,314
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-02-06+$9,941$9,941MATULANE
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2019-08-08−$6,628$3,314MATULANE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI XEEKF6DJLC34)

AwardOffice · PSC / listingNet obligationsFY
36E79722A0005NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36F79721D0236NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36C24920N0493249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$5,443FY2020
36C26320F0037NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$5,443FY2020
36C24919N0474249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$5,351FY2019
36C24919N0265249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$3,945FY2019

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018N0488_3600_V797D40224_3600 · retrieved 2026-09-26.